-
Cash is king and chain drug is on an upswing
NEW YORK — The Motley Fool on Tuesday suggested all three national pureplay drug chains were in a better position today than five years and three years ago based on a metric called the “cash king margin.”
The metric teases out the amount of free cash flow a company actually can use to monetize shareholder value by paying dividends or buying back stocks. Companies that can create cash king margins (calculated by dividing free cash flow by sales) of more than 10% are the most attractive to investors, the Fool surmised.
-
Sherwin-Williams sales up 18% for Q4
Cleveland-based Sherwin-Williams reported fourth-quarter net income of $72.9 million, up 11.6% from $65.3 million reported for the same period last year.
Sales for the quarter ended Dec. 31 were $1.89 billion, up 18.8% from $1.59 billion reported for the same period in 2009.
For the full year, the company reported net income of $462.4 million, up 6.1% from $435.8 million for fiscal year 2009.
Sales for 2010 totaled $7.77 billion, up 9.5% from $ 7.09 billion reported last year.